Home
Focus Areas
About Us
Liver disease is a "huge global health problem" with an estimated 1.5 billion people worldwide affectedand no treatment has worked yet, Dr. Prakash Ramachandran writes in the Conversation.
That's because different factors are at play in different stages of the disease, which can lead to cirrhosis, cancer, and liver failure.
One of the biggest factors is fibrosis, which is caused by damage to the liver's epithelial cells.
It can take years for the disease to develop, and no treatment has worked yet.
But Ramachandran and his team at the University of Edinburgh are reporting in the Proceedings of the National Academy of Sciences that they've found a way to map out fibrosis in a way that could lead to new treatments.
They're calling it Liver Cell Analysis, or LiCA, which allows them to take a patient's liver biopsy and blood samples and "build up a high-resolution profile of changes in cells, genes, and proteins in different types of liver disease and at different stages of disease progression," as Ramachandran puts it.
"This means we can nail down which pathways in the liver are associated with different clinical outcomes in a way others cannot."
The team has already started a clinical trial of LiCA in patients with non-alcoholic fatty liver
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
"One day there will be a cure," Ashkan Novin says. "And I hope that we will play a part in that." Novin, a PhD candidate at the University of Connecticut, is the winner of the school's...more
When Matthew Love took over as CEO of Nicklaus Children's Hospital in Palm Beach, Fla., four years ago, the hospital was losing about $40 million a year. "We were in a solid market position,...more
If you're looking for a new job, there's a good chance you'll soon find one in Maine. Gov. Janet Mills announced Tuesday that more than 111,000 health care jobs have been created in the state...more
Some 24 million people in 128 low- and middle-income countries now have access to HIV treatments that once would have cost tens of thousands of dollars a year, the BBC reports. According to a...more
Kaakpema Yelpaala grew up in Kenya, attended Harvard, and now lives in Yale, where he's a professor and the new director of the university's health technology program, the New York Times...more
"We are in an age of incredible innovation" in the health care industry, writes Lee Murray in a blog post about a meeting with a private equity investor. Murray's mother in law suffered two brain...more
"Access to financial advice and banking services is essential for any community to thrive and our Community Center Branches are at the center of lifting up communities by creating opportunities for...more
It's World Intellectual Property Day, and the pharmaceutical industry is taking note. In a press release, the industry's trade group, the Pharmaceutical Research and Manufacturers Association,...more
The Star-Friedman Challenge, an annual contest that aims to spur cutting-edge scientific research, has announced its 2024 winners. Among the winners: a study on fat-handling organelles in...more
"We're like the kindling that gets the fire going," says Dr. Bryan Hartley, an associate professor of Radiology and Radiological Sciences at Vanderbilt University Medical Center who's working on a...more
Health News from...
Gates Foundation
Johnson Foundation
Robert Wood Johnson Foundation
Silicon Valley Community Foundation
California Endowment
California Community Foundation
Lancaster County Community Foundation
Community Foundation of Southern Indiana
Community Giving Foundation
Hawaii Community Foundation
Social Entrepreneurship
Spotlight
Social Entrepreneurship: Meet the Disruptors of The World Of Philanthropy
William D. Eggers and Paul Macmillan of Dowser write about the social entrepreneurs slowly and steadily dirsupting the world of philanthropy. According to Forbes, philanthropy disruptors are those that believe “no one company is so vital that it can’t be replaced and no single business model too perfect to upend.”
